SCM
GILD icon

Saxony Capital Management’s Gilead Sciences GILD Stock Holding History

Saxony Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Sell
1,735
-38
-2% -$5.01K 0.1% 167
2026
Q1 		$247K Buy
1,773
+93
+6% +$13K 0.14% 131
2025
Q4 		$206K Buy
+1,680
New +$204K 0.13% 150
2024
Q4 		– Sell
-2,426
Closed -$203K – 139
2024
Q3 		$203K Buy
+2,426
New +$185K 0.19% 128

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Saxony Capital Management's GILD Position: Q2 2026 in Review

Saxony Capital Management reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $5.01K and leaving 1,735 shares worth $219K. The position accounts for 0.1% of the portfolio, ranked #167.

Saxony Capital Management first reported a position in GILD in Q3 2024 and has held it in 4 quarters since. The position peaked at $247K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Saxony Capital Management held 1,735 shares of Gilead Sciences worth $219K as of Q2 2026.
  • Saxony Capital Management sold 38 Gilead Sciences shares in Q2 2026, an estimated $5.01K.
  • Gilead Sciences made up 0.1% of Saxony Capital Management's portfolio in Q2 2026, its #167 holding.
  • Saxony Capital Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 4 quarters since.
  • Saxony Capital Management's Gilead Sciences position peaked at $247K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Saxony Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.